Gilead's twice-yearly HIV injection faces headwinds from US aid pullback. Gilead Sciences says it still plans to supply its ...

The government is now targeting 15,000 Ugandans for new HIV/AIDS data study COVER STORY | RONALD MUSOKE | On May 29, the ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.